The findings of this study indicate that measuring tumor markers CEA and CA 19-9 in peritoneal lavage fluid (pCEA and pCA 19-9) may serve as a valuable tool in assessing the advancement of colorectal cancer (CRC), particularly in the context of peritoneal dissemination. This evidence concerns the gene CEACAM5 and neoplasm.